Company Filing History:
1 out of 27 
1 out of 2,009 
1 out of 987 
Years Active: 2008
Title: Innovations by Jennifer C Darnell
Introduction
Jennifer C Darnell is a notable inventor based in Pelham, NY (US). She has made significant contributions to the field of molecular biology, particularly in understanding fragile X syndrome and associated disorders. Her innovative work has led to the development of methods and compositions that have the potential to impact therapeutic approaches.
Latest Patents
Jennifer C Darnell holds one patent titled "Method and identification of downstream mRNA ligands to FMRP and their role in fragile X syndrome and associated disorders." This patent provides compositions and methods for identifying and/or modulating RNA transcripts and/or genes involved in fragile X syndrome and other associated disorders. In particular, her work has identified RNA targets for fragile X mental retardation protein (FMRP) through a novel monoclonal antibody to FMRP. Additionally, a consensus sequence for the RNA binding region has been identified, along with arrays for identifying compounds, proteins, nucleotides, and the like that modulate the RNA targets or associated genes. Furthermore, methods for modulating RNA targets are also provided in her patent.
Career Highlights
Throughout her career, Jennifer has worked at prestigious institutions such as Rockefeller University and Duke University. Her research has focused on the molecular mechanisms underlying fragile X syndrome, contributing to a deeper understanding of this genetic disorder.
Collaborations
Jennifer has collaborated with notable colleagues, including Stephen T Warren and Victoria Brown-Kennerly. These collaborations have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Jennifer C Darnell's innovative contributions to the field of molecular biology, particularly regarding fragile X syndrome, highlight her role as a leading inventor. Her patent and collaborative efforts reflect her commitment to advancing scientific knowledge and potential therapeutic solutions.